Hemophilia care in China: review of care for 417 hemophilia patients from 11 treatment centers in Shanxi Province.

Authors :: Zhao H
Yang L
Long C
Guo Y
Wu R
Liu X
Qin X
Liang H
Duan Z
Source :: Expert review of hematology [Expert Rev Hematol] 2015 Aug; Vol. 8 (4), pp. 543-50. Date of Electronic Publication: 2015 May 06.
Publication Year :: 2015
Abstract: Aims: We analyzed the clinical features of 417 patients with hemophilia from 11 Hemophilia Treatment Centers in Shanxi Province (SP) in China.<br />Methods: We used data collected in the national registry of hemophilia A and hemophilia B in SP from January 2010 to December 2013.<br />Results: Ratio of hemophilia A:hemophilia B patients was 5:1, of which 48% (200/417) were severe, 31% (129/417) moderate and 21% (88/417) mild. Episodes of joint bleeding occurred in 73% (305/417) of patients. Only 4% (15/417) of patients received tertiary prophylaxis. Three percent of patients (2/72) were hepatitis B virus-Ab positive, and 7% (5/72) of patients were hepatitis C virus-Ab positive. The incidence of inhibitors was 6% (11/182).<br />Conclusion: The ability to manage hemophilia in SP remains suboptimal. However, due to limited data, the evaluation and extrapolation of large hemophilia populations in SP are restricted, therefore, further studies with a large cohort are needed.

Full Text Access

Tools